|
|
Volumn 28, Issue 1, 2002, Pages 105-109
|
|
Combination antipsychotics: Pros, cons, and questions
|
|
Author keywords
Antipsychotic agents; Combination; Drug therapy; Polypharmacy; Schizophrenia
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
PSYCHOTROPIC AGENT;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SULPIRIDE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DATA BASE;
DRUG COST;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
POLYPHARMACY;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
SIDE EFFECT;
CLINICAL PATHWAY;
DRUG COMBINATION;
DRUG INTERACTION;
PSYCHOLOGY;
TREATMENT OUTCOME;
ANTIPSYCHOTIC AGENTS;
CLINICAL TRIALS;
CLOZAPINE;
CRITICAL PATHWAYS;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
TREATMENT OUTCOME;
|
|
EID: 0035988577
PISSN: 05867614
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.schbul.a006912 Document Type: Article |
|
Times cited : (84)
|
|
References (18)
|
